Article Details
Retrieved on: 2019-03-09 22:54:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. decreased its holdings in Regulus Therapeutics Inc (NASDAQ:RGLS) by 1.5% in the third quarter, according to the company in ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here